Dr (MD) Claudia Schilling
Central Institute of Mental Health (CIMH), Mannheim, Germany
Presentation
BMBF-Forschungsverbund: SLEEP-NEURO-PATH - Beitrag schlafbezogener Biomarker zur Pathophysiologie von ME/CFS
Dr Claudia Schilling is a psychiatrist, neurologist and sleep specialist. She is the head of the sleep laboratory and of the research group "Neuropsychiatric Sleep Disorders" at the Central Institute of Mental Health (CIMH) in Mannheim, Germany. Her research focusses on the contribution of sleep disturbance and sleep microstructure to aetiological models of mental illness. At the centre of her studies lie neurophysiological sleep-related aspects of schizophrenia, insomnia disorder and, more recently, post-COVID syndrome. As a clinical care offer for patients with post-COVID syndrome, and at the same time as a basis for associated research projects, Dr Schilling set up a post-COVID outpatient clinic at CIMH in May 2021. She also supported the state-wide EPILOC consortium in Baden-Wuerttemberg, where she was responsible for neuropsychiatric aspects across the different study sites. Dr Schilling leads the "Contribution of sleep-related biomarkers to the pathophysiology of ME/CFS (SLEEP-NEURO-PATH)" research network funded by the Federal Ministry of Education and Research (BMBF).